Greenwich LifesciencesGLSI
13F holders, Q1 2024 (March 31)31holders
2famous investors
$19.94avg. 13F price*
At the end of Q1 2024, 31 institutions reported holding Greenwich Lifesciences Inc. (GLSI) in their 13F filings. The largest holders were Vanguard Group Inc. ($4.4M), Millennium Management ($1.3M) and Geode Capital Management, LLC ($1.2M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Greenwich Lifesciences Inc.
- CUSIP
- 396879108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.1M |
| Exits | 3 | $771K |
Ownership 31 holders
| Vanguard Group Inc. | 0.00% | Add +0.6% | 223,102 | $4.4M |
| Millennium Management | 0.00% | Add +454.4% | 63,811 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +24.4% | 58,244 | $1.2M |
| BlackRock Inc. | 0.00% | Reduce -1.2% | 56,459 | $1.1M |
| Goldman Sachs Group Inc. | 0.00% | New | 41,505 | $828K |
| Renaissance Technologies | 0.00% | Add +2.5% | 37,500 | $748K |
| Susquehanna International Group, LLP | 0.00% | New | 35,870 | $715K |
| Northern Trust Corp. | 0.00% | Add +1.1% | 21,215 | $423K |
| Jane Street Group, LLC | 0.00% | Add +47.4% | 20,642 | $412K |
| Qube Research & Technologies Ltd | 0.00% | Add +17.7% | 17,317 | $345K |
| HRT Financial LP | 0.00% | New | 15,165 | $302K |
| State Street Corp. | 0.00% | No change | 13,002 | $259K |
| Man Group plc | 0.00% | New | 11,365 | $227K |
| Citigroup Inc. | 0.00% | Reduce -13.3% | 8,257 | $165K |
| Morgan Stanley | 0.00% | Add +2125.0% | 6,230 | $124K |
| JPMorgan Chase & Co. | 0.00% | Add +1.7% | 5,672 | $113K |
| Bank of America Corp. | 0.00% | Add +16.4% | 5,635 | $112K |
| NFSG Corp | 0.01% | No change | 1,500 | $30K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -63.1% | 530 | $11K |
| Founders Capital Management | 0.01% | No change | 500 | $10K |
| UBS Group AG | 0.00% | Reduce -78.2% | 402 | $8K |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 200 | $4K |
| Washington Trust Advisors, Inc. | 0.00% | No change | 200 | $4K |
| Towne Trust Company, N.A | 0.00% | New | 100 | $2K |
| FMR LLC | 0.00% | No change | 90 | $2K |
| Geneos Wealth Management Inc. | 0.00% | No change | 88 | $2K |
| North Star Investment Management Corp. | 0.00% | No change | 51 | $1K |
| Wells Fargo & Company | 0.00% | No change | 41 | $818 |
| Macquarie Group Ltd. | 0.00% | New | 110 | $2 |
| Royal Bank of Canada | 0.00% | Reduce -41.7% | 14 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | New | 3 | $0 |
"% of holder's portfolio" is GLSI's weight in each manager's 13F, not the share of Greenwich Lifesciences Inc. the manager owns.